Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DES PLEIADES : revenue, balance sheet and financial ratios

SELARL PHARMACIE DES PLEIADES is a French company founded 17 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-PIERRE-EN-FAUCIGNY (74800), this company of category PME shows in 2025 a net income positive of 77 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - SELARL PHARMACIE DES PLEIADES (SIREN 508626413)
Kennzahl 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Umsatz N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C
Nettoergebnis 76 793 € 98 322 € 98 829 € 121 383 € 91 030 € 66 288 € 74 368 € 99 199 € 94 670 € 86 779 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C
Nettomarge N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2025, SELARL PHARMACIE DES PLEIADES generates positive net income of 77 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 87 k€ -> 77 k€.

Nettoergebnis (2025) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

76 793 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 52%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Verschuldungsgrad (2025) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

52.228%

Finanzielle Autonomie (2025) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

57.024%

Anlagenaltersquote (2025) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

47.5%

Entwicklung der Solvenzkennzahlen
SELARL PHARMACIE DES PLEIADES

Positionnement sectoriel

Debt ratio
52.23 2025
2023
2024
2025
Q1: 13.57
Méd: 49.47
Q3: 128.28
Average

In 2025, the debt ratio of SELARL PHARMACIE DES PLEI... (52.23) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
57.02% 2025
2023
2024
2025
Q1: 33.69%
Méd: 53.88%
Q3: 72.26%
Good +7 pts über 3 Jahre

In 2025, the financial autonomy of SELARL PHARMACIE DES PLEI... (57.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 254.90. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2025) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

254.904

Entwicklung der Liquiditätskennzahlen
SELARL PHARMACIE DES PLEIADES

Positionnement sectoriel

Liquidity ratio
254.9 2025
2023
2024
2025
Q1: 131.48
Méd: 182.6
Q3: 258.72
Good

In 2025, the liquidity ratio of SELARL PHARMACIE DES PLEI... (254.90) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positionnement de SELARL PHARMACIE DES PLEIADES dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE DES PLEIADES is estimated at 1 219 865 € (range 827 806€ - 1 914 137€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
827k€ 1219k€ 1914k€
1 219 865 € Range: 827 806€ - 1 914 137€
NAF 5 année 2025

Valuation method used

Net Income Multiple
76 793 € × 15.9x = 1 219 866 €
Range: 827 807€ - 1 914 138€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DES PLEIADES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DES PLEIADES

What is the revenue of SELARL PHARMACIE DES PLEIADES ?

The revenue of SELARL PHARMACIE DES PLEIADES is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DES PLEIADES profitable?

Yes, SELARL PHARMACIE DES PLEIADES generated a net profit of 77 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE DES PLEIADES ?

The headquarters of SELARL PHARMACIE DES PLEIADES is located in SAINT-PIERRE-EN-FAUCIGNY (74800), in the department Haute-Savoie.

Where to find the tax return of SELARL PHARMACIE DES PLEIADES ?

The tax return of SELARL PHARMACIE DES PLEIADES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DES PLEIADES operate?

SELARL PHARMACIE DES PLEIADES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.